Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4777
Source ID: NCT00437008
Associated Drug: Benfotiamine 1050mg, 3 Days
Title: Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes
Acronym: AGE-Benfo
Status: COMPLETED
Study Results: NO
Results:
Conditions: Endothelial Dysfunction|Type 2 Diabetes Mellitus
Interventions: DRUG: Benfotiamine 1050mg, 3 days|BEHAVIORAL: high-AGE vs. low-AGE meal
Outcome Measures: Primary: A high-AGE meal causes a more pronounced postprandial endothelial dysfunction comparing to a low-AGE meal in people with type 2 diabetes mellitus. | Secondary: The influence of high-AGE vs. low-AGE meal on the laboratory parameters that mirror AGE-metabolism, oxidative stress, endothelial dysfunction and inflammation shall be investigated.|To investigate whether treatment with Benfotiamine 1050mg/day for 3 days has a protective effect on endothelial function after a high-AGE meal
Sponsor/Collaborators: Sponsor: Ruhr University of Bochum
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 21
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE|Primary Purpose: PREVENTION
Start Date: 2004-11
Completion Date: 2006-01
Results First Posted:
Last Update Posted: 2007-02-19
Locations: Heart and Diabetes Center NRW, Bad Oeynhausen, 32545, Germany
URL: https://clinicaltrials.gov/show/NCT00437008